ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2018

Juvenile Idiopathic Arthritis in Adulthood: Evaluation of Disease Activity, Damage and Quality of Life

Alessandra Salmaso1, Lorenzo Ceri2, Serena Capannini2, Francesco La Torre3, Maurizio Gattinara4, Irene Pontikaki1, Pier Luigi Meroni5, Fernanda Falcini2 and Valeria Gerloni1, 1Pediatric Rheumatology, G. Pini Institute, Department and Chair of Rheumatology, Milan, Italy, 2Department of Internal Medicine, Rheumatology Section, Transition Clinic, University of Florence, Firenze, Italy, 3DIMIMP-University, Rheumatologic Section, Bari, Italy, 4Pediatric Rheumatology, Pediatric Rheumatology, G. Pini Institute, Department and Chair of Rheumatology, Milan, Italy, 5Dept. of clinical and community science, Division of Rheumatology, Istituto G. Pini, University of Milan, Milano, Italy

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: : Health outcomes in Juvenile Idiopathic Arthritis (JIA) have been a very active area of research in the past several years. Altogether, the available data indicate that a considerable number of patients with JIA enters adulthood with persistently active disease and a significant proportion of them may develop severe physical disability. In general children with polyarticular course are more likely to have erosive radiological damage on follow-up. The comparison of earlier studies with those published in the last decade shows a decline in the frequency of patients with severe physical disability over the years; however, patients who enter adulthood with active disease do not seem to be diminished. The purpose of this study is to evaluate in patients with JIA in adulthood the functional and anatomic damage and the quality of life.

Methods: All consecutive JIA patients aged >18 yrs, afferent to three different paediatric rheumatology centres in the last year, were assessed with: HAQ; SF36; active joint count; VAS (0-100 mm) for pain, patient and physician global health assessment; radiological evaluation (Steinbrocker classification).

Results: 347 patients with JIA in adulthood, age >18 yrs, were enrolled. The collected data are shown in the following table

JIA IN ADULTHOOD, age >18 yrs

JIA all

Syst

Poly RF+

Poly RF-

Oligo pers

Oligo ext

Psor

ERA

# pts

347

41

22

60

122

50

14

38

Mean age

27(17-52)

30(18-52)

26(18-42)

27(18-51)

26(18-44)

28(18-46)

28(19-44)

25(18-39)

Mean disease duration

19(3-51)

21(3-48)

15(4-30)

18(3-51)

19(6-40)

22(6-43)

22(6-43)

14(3-31)

Active arthritis(%)

40

46

43

48

38

38

29

32

Mean VAS pain

24(0-100)

36(0-100)

25(0-70)

24(0-88)

22(0-82)

21(0-88)

22(0-62)

22(0-84)

Mean patient GH

71(0-100)

62(0-100)

77(30-100)

70(0-100)

74(24-100)

72(10-100)

65(40-90)

72(20-100)

Mean VAS physician

15(0-100)

22(0-100)

19(0-75)

17(0-90)

12(0-70)

15(0-50)

17(0-94)

12(0-60)

% anatomic class III-IV

45

72

71

53

25

60

50

30

% pts with protesis

11

49

10

12

1

15

21

0

Mean HAQ

0,5(0-3)

0,8(0-3)

0,4(0-2)

0,4(0-3)

0,2(0-1,6)

0,3(0-1,3)

0,4(0-1,8)

0,1(0-0,8)

Mean SF36 physical health

62(1-99)

50(1-97)

62(25-97)

62(11-99)

65(13-99)

66(15-99)

50(22-80)

59(12-98)

Mean SF36 mental health

63(12-100)

61(12-93)

63(22-99)

62(11-99)

64(13-100)

68(20-100)

51(21-90)

60(30-98)

Conclusion: this hospital-based study clearly shows a selection bias toward the most serious cases, but underlines the high rate of JIA patients with disease still active in adulthood, confirming the need of a more aggressive and precocious treatment, to improve outcome in the future.


Disclosure:

A. Salmaso,
None;

L. Ceri,
None;

S. Capannini,
None;

F. La Torre,
None;

M. Gattinara,
None;

I. Pontikaki,
None;

P. L. Meroni,
None;

F. Falcini,
None;

V. Gerloni,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/juvenile-idiopathic-arthritis-in-adulthood-evaluation-of-disease-activity-damage-and-quality-of-life/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology